Hemant Thukral, National Head-Derivative Desk at Aditya Birla Money is of the view that Vedanta may test Rs 270-272.
He further added, "Bharat Forge is on some serious upmove and that momentum will continue. The way the open interest has added up yesterday, 6 percent fresh longs have been added up. Technically stock has seen a clear breakout now above Rs 1,065, which was acting as a resistance in weekly charts also. So now we feel, it is heading towards Rs 1,125 to Rs 1,130 and one can keep a tight stoploss of Rs 1,060 from where it has given a breakout. So both these stocks are valid till February expiry that is next two-three trading sessions."
"I like Aurobindo Pharma more. The way this stock has rebounded back after being battered down till Rs 625-630, it has been a very old support from where it has rebounded monthly support. We expect it to rebound that to Rs 660-662. So I would be looking out to buying opportunities in Aurobindo Pharma now," he said.